Healthcare
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
10 Jan 2017 | Europe | Market Research
Custom Procedure Trays and Packs in Western and Eastern Europe, Forecast to 2021
With Heavy Commoditization and Low-cost Manufacturing, Product-driven Business Models are Transitioning to Service-driven Models
This research service presents a detailed analysis of the European Custom Procedure Trays and Packs (CPTP) market. It provides an in-depth analysis of the market size, revenue forecast, overall as well as by surgical custom procedure trays and packs and minor procedure trays and packs and by packaging type (boxes, wraps and moulds). The surgical se...
$4,950.00 -
02 Feb 2017 | Europe | Market Research
Spain’s New Business Models in Medical Imaging, Forecast to 2020
Customer-Vendor Partnerships Find Windows of Opportunity Amidst a Deepening Public-Private Healthcare Divide
Low economic growth and limited access to capital funding compel hospitals in Spain to adopt new purchasing and service models for imaging equipment. The drive to operationalize capital and service costs favors non-conventional business models in Spain over traditional capital-intensive purchasing and service models. Vendor-customer engagement over...
$4,950.00 -
02 Feb 2017 | Europe | Market Research
European Next-generation Sequencing Services Market, Forecast to 2023
Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth
The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...
$4,950.00 -
29 Mar 2017 | Europe | Market Research
Biosimilars Market, Europe, Forecast to 2025
A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter
Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...
$4,950.00 -
25 Sep 2017 | Europe | Market Research
Growth Opportunity Assessment of Healthcare IT Market in France, Forecast to 2021
eHealth Strategy 2020 and Digital Hospital Programme to Elevate Maturity of HCIT in France
UK, Germany, France and Spain collectively spend more than $6 billion on healthcare information technology (healthcare IT) while regional adoption stands at almost 80%. Healthcare IT markets in these countries are ready to embark upon the next level of digitalisation where providers move from data capturing solutions to those that can derive value ...
$3,000.00 -
28 Sep 2017 | Europe | Market Research
Italy's New Business Models in Medical Imaging, Forecast to 2021
An Established Market for Multivendor Services Ripe for Progressive Managed Contracts
This research study focuses on the drive to operationalize capital and service costs favoring non-conventional business models (MES and MVS) in Italy over traditional capital-intensive purchasing and service models. The study also features a detailed elaboration on the legacy of public-private partnerships (PPP), framework agreement case studies, m...
$4,950.00 -
30 Nov 2017 | Europe | Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00
